The Impact of Glycemic Index Education on Lowering Dietary GI in Gestational Diabetes Mellitus

March 29, 2022 updated by: Shannan Grant, IWK Health Centre

Adapting a National Glycemic Index Education Platform for Nova Scotian Patients and Clinicians Treating Gestational Diabetes Mellitus Using Distance Education Strategies.

Gestational Diabetes Mellitus (GDM) incidence is increasing worldwide, and within Canada, the Atlantic provinces statistically have been found to have highest prevalence of diabetes. Increasing evidence supports the benefit of following a low glycaemic index (GI) diet in GDM and the Canadian Diabetes Guidelines recommends replacing high GI foods for low GI foods. Despite recommendation to adapt a low GI diet in GDM, there are limitations and barriers recognized to GI utility largely focused on knowledge translation. There is sufficient research to support a low GI diet in benefiting outcomes of GDM, therefore the GI in GDM Online trial will investigate the feasibility and effectiveness of a distance low GI education intervention, adapted from Diabetes Canada's GI materials, on producing a difference in average dietary GI between a group with the intervention and standard care.

Study Overview

Status

Recruiting

Detailed Description

The incidence of Gestational Diabetes Mellitus (GDM) has been progressively increasing worldwide, with a global prevalence of gestational hyperglycaemia estimated at 16.9%. In Canada, Atlantic provinces have been recorded with the highest prevalence of diabetes at 6%. The Diabetes Canada Practice Guidelines recommends the low glycemic index (GI) diet to type 1 and 2 diabetes mellitus and has recently updated its guidelines to include a recommendation for GDM. This said, barriers to GI knowledge translation have been identified. This study uses a prospective parallel randomized control trial design. Procedures and materials have been adapted from NCT01589757. The Kirkpatrick Model (Reaction, Learning, Behaviour, and Results) informed intervention development and evaluation strategies. The purpose of this study is to evaluate whether a distance low GI education intervention, adapted from Diabetes Canada's GI education materials, will significantly yield a lower average GI (primary outcome) in participants than traditional standard care medical nutrition therapy for Gestational Diabetes Mellitus. We hypothesize that participants who receive the low GI intervention will have a lower dietary GI than those who received usual IWK standard care for GDM.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Of or over 18 years of age
  • Diagnosed with GDM according to Diabetes Canada
  • At or over than 20 weeks gestation
  • At or less than 32 weeks gestation
  • Being followed at IWK Health Centre
  • Willing and able to give informed consent
  • Willing and able to complete study protocol
  • Currently living in Nova Scotia

Exclusion Criteria; women who:

  • have been diagnosed with acute or chronic illness, other than GDM and PCOS, that may impact carbohydrate digestion metabolism.
  • are currently taking a medication (other than insulin) that may affect carbohydrate metabolism.
  • have multi-fetal pregnancy in current pregnancy.
  • have insurmountable language barriers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Standard Care
Participants will attend a 30-45 min workshop. Trainees will review Diabetes Canada Clinical Practice Guidelines Job Aids (Just the Basics, the Handy Portion Guide, and Basic Carbohydrate Counting) and teach data provision skills (how to complete a three day diet record).
EXPERIMENTAL: Low Glycemic Index
Standard care + Glycemic Index. Participants will attend a 30-45 min workshop. Trainees will review Diabetes Canada Clinical Practice Guidelines Job Aids (Just the Basics, the Handy Portion Guide, and Basic Carbohydrate Counting) and teach data provision skills (how to complete a three day diet record). Diabetes Canada and Dietitian's Canada resources on glycemic index will also be reviewed: the Glycemic Index Food Guide, Flip Cards, and Recipes.
Educational materials layering Glycemic Index education onto Canada's Food Guide and Diabetes Canada recommendations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transfer/KM Level 3: Change in average dietary GI
Time Frame: From baseline to 4-6 weeks postpartum
Average dietary GI; diet record at baseline, 4-6 weeks post-intervention, 4-6 weeks postpartum
From baseline to 4-6 weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction/ KM Level 1: Reaction
Time Frame: From baseline to 4-6 weeks postpartum
Mixed form Questionnaire (GIQ): Close ended format with True or False, Multiple Choice, and Likert Scale choices. Open-ended questions for feedback.
From baseline to 4-6 weeks postpartum
Knowledge/KM Level 2: Learning
Time Frame: From baseline to 4-6 weeks postpartum
Average Quiz Score: Close-ended format, Scored by correct answers.
From baseline to 4-6 weeks postpartum
Acceptability and Applicability of Education/KM Level 3: Transfer (Behaviour Change)
Time Frame: From 4-6 weeks post-intervention to 4-6 weeks post-partum
Mixed form Questionnaire (GIQ): Close ended format using Likert Scale and True or False choices. Open-ended questions for feedback.
From 4-6 weeks post-intervention to 4-6 weeks post-partum
Results/KM Level 4: Glycemic Control (rate of Self-monitored blood glucose levels within range)
Time Frame: From Baseline to 4-6 weeks post-partum
Medical Record (standard care 2-4 time-points per day)
From Baseline to 4-6 weeks post-partum
Maternal Demographics (eg. age, ethnicity, language spoken, education level and work status)
Time Frame: Baseline
Mixed-form Questionnaire (GIQ) and Medical Chart
Baseline
Maternal Height
Time Frame: Baseline
Medical Record, measured in cm.
Baseline
Maternal Pre-Pregnancy body weight
Time Frame: Baseline
Medical Record, measured in kg.
Baseline
Maternal Weight, during pregnancy
Time Frame: From Baseline to 4-6 weeks post-partum.
Medical Record, measured in kg.
From Baseline to 4-6 weeks post-partum.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shannan Grant, PhD, PDt, IWK Health Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 24, 2019

Primary Completion (ANTICIPATED)

May 31, 2022

Study Completion (ANTICIPATED)

August 30, 2022

Study Registration Dates

First Submitted

October 20, 2019

First Submitted That Met QC Criteria

February 14, 2020

First Posted (ACTUAL)

February 17, 2020

Study Record Updates

Last Update Posted (ACTUAL)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 29, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gestational Diabetes Mellitus

Clinical Trials on Low Glycemic Index Education

3
Subscribe